Akebia Therapeutics (AKBA) Preferred Dividend Payments (2013 - 2014)

Akebia Therapeutics (AKBA) reported Preferred Dividend Payments of -$1000.0 for Q3 2014, down 200.0% quarter-over-quarter from $1000.0 in Q2 2014.

Akebia Therapeutics (AKBA) Preferred Dividend Payments (2013 - 2014) Analysis & Trends

Akebia Therapeutics (AKBA) has 2 years of Preferred Dividend Payments data on file, last reported at -$1000.0 in Q3 2014.

Preferred Dividend Payments for Q3 2014 came in at -$1000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was $86.9 million (changed N/A YoY), and the FY2014 annual result was $86.9 million, up 55.49% from the prior year.
Preferred Dividend Payments declined to -$1000.0 in Q3 2014 per AKBA's latest filing, from $1000.0 in the prior quarter.
Over five years, Preferred Dividend Payments peaked at $86.9 million in Q1 2014 and troughed at -$1000.0 in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-
10	Akebia Therapeutics	243.23 Mn	80.63 Mn	41.25 Mn	-

Download Data